Press Releases
May 7, 2025
Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly
Indeterminate
GlobeNewswire, Inc.
May 12, 2025
Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States
Indeterminate
GlobeNewswire, Inc.
April 15, 2025
Nüspace Celebrates 20 Years: From a Taxi Garage to a Montreal Design Destination
Indeterminate
GlobeNewswire, Inc.
April 1, 2025
Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above
Indeterminate
GlobeNewswire, Inc.
March 31, 2025
Valneva Submits Adolescent Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to UK MHRA
Indeterminate
GlobeNewswire, Inc.
March 4, 2025
NEW LITERARY COLLECTION REDEFINES LOVE AND HUMAN CONNECTIONS THROUGH DARING AND INTRIGUING TAKES
Neutral
EIN Presswire